TROOPS, Inc. (Nasdaq: TROO) (the “Company” or “TROOPS”) today announced that the Company has received a judgement (the “Judgement”) issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no. HCA 938/2022. As previously disclosed, on August 9, 2022, TROOPS, Inc. (the “Company”) and certain […]

Today, the Honourable Julie Dabrusin, Minister of Environment and Climate Change, visited Denendeh Manor, a four-storey Indigenous-owned apartment building in Yellowknife, toannounce over $13.3 million in support of five projects in Alberta and the Northwest Territories. These projects are being funded under the Low Carbon Economy Fund (LCEF), which invests in projects that reduce greenhouse

(NASDAQ:MERC), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC), a global forest products company with operations in Germany, the U.S., and Canada, announces that it has received an updated ESG Risk Rating of 16.8 from Sustainalytics. This updated score reflects continued improvement from its 2024 rating

(NASDAQ:OLMA), SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 154,500

(NASDAQ:XLO), WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options to purchase 10,700 shares of its common stock to two new employees under

(NASDAQ:ITRM), DUBLIN and CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum” or the “Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant pathogens, today announced that it has granted a non-statutory share option to purchase an aggregate of 200,000 ordinary

(NYSE:TOL), FORT WASHINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation's leading builder of luxury homes, through its Toll Brothers Apartment Living(R) rental division, and Gables Residential have announced a new joint venture to develop Gables Angeline, a four-story, 243-unit luxury multifamily rental community in Littleton, Colorado. The

(NasdaqGM:BIGC), AUSTIN, Texas, July 02, 2025 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced it will report its financial results for the second quarter ended June 30, 2025, before market open on Thursday, July 31, 2025.

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 02, 2025 SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 02, 2025 WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options